This lecture will discuss the appropriate follow-up of patients treated for the most common cancers. This will include breast cancer, colorectal cancer, Hodgkin's and non-Hodgkin's lymphoma, prostate cancer, and lung cancer. An in-depth discussion of the physical challenges and psychological impacts of a cancer diagnosis and its treatment will prepare you to help your patients with what lies ahead.
Dr. Nangia will discuss cancer survivorship, and will review what long term follow-up cancer patients need. This section will also cover potential long term and late adverse events cancer patients can experience and how to manage them. Learn what survivorship care plans are and how they can help primary care providers. Dr. Gramatges will present an overview of late effects experienced by survivors of childhood cancer, focusing on general patterns, common outcomes, and excess morbidity/mortality risk. She will also discuss follow up patterns and distribution (primary care vs. oncology specialty care), need for subspecialty care, and the concept of a ‘shared-care’ model. Dr. Gramatges will introduce the evidence-based guidelines for childhood cancer survivors, where they may be accessed for public use, and strategies for guidelines dissemination and adherence, such as Passport for Care.
What do primary care providers need to know about pneumonia disease, insomnia, and colorectal cancer screening? Join expert faculty as they review important questions they get asked about these topics!
What do primary care providers need to know about geriatric cancer screening and HIV? Join expert faculty as they review important questions they get asked about these topics!
What do primary care providers need to know about women's health? Join expert faculty as they review important questions they get asked about osteoporosis, and breast cancer care and screening!
Episode 6: Coffee with Chopra
Are opioids effective in chronic pain management? Join neurologist and pain specialist, Dr. Charles Argoff, as he summarizes two recent trials published in JAMA examining the efficacy of opioids in pain management and discusses their clinical implications. This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA). Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 11/23/2020 and they are subject to change as new information is published.
In this CE podcast, two experts discuss prevalence, mortality rates and screening guidelines for hepatocellular carcinoma.